The ISN is pleased to welcome the Indian Society of Nephrology (Indian SN) as its newest collective-member society, creating additional opportunities for Indian SN members to connect with the global kidney health community and access ISN Grants and initiatives. The two societies have collaborated since 2015 to strengthen kidney care capacity in India and South...
As Kidney International Reports® (KIR) marks its tenth anniversary, Editor-in-Chief Jai Radhakrishnan reflects on the trust, teamwork, and willingness to innovate that have shaped the journal from its earliest days. "KIR belongs to the community," he says, "When the journal was new, and its future uncertain, authors and reviewers placed their confidence in it. Their...
Kidney International® Kidney stone disease – to drink or not to drink, that is the question Increasing fluid intake is widely recommended to prevent kidney stone recurrence, but many patients struggle to maintain adequate hydration. This editorial examines the PUSH trial, which tested interventions to increase fluid intake and achieve the recommended urine output of 2.5 liters...
The ISN-led Global Environmental Evolution in Nephrology and Kidney Care (GREEN-K) initiative has launched its Joint Statement on Procurement (JSP). GREEN-K is now seeking support from kidney health societies worldwide to help build a shared approach to procurement that benefits patients and the environment. Read the Joint Statement on Procurement and encourage your national or regional...
How can medicine be engineered to reach the right place in the body, enter the right cells, and release its treatment at the right time? At WCN’27, Kazunori Kataoka’s plenary, “Engineering Smart Nanomedicines to Navigate the Human Body,” will offer a glimpse into how advances in materials science and bioengineering could transform the way treatments...
Discover the first results of the landmark "Prepare for Kidney Care" randomized controlled trial in a recording of the ISN-UKKA* webinar, attended by over 700 participants worldwide when it aired live, accompanied by simultaneous publication in The Lancet. The trial compared preparation for dialysis with preparation for conservative kidney management in older people approaching kidney...
Kidney International® A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease Somatostatin analogues can reduce cyst volume in autosomal dominant polycystic kidney disease (ADPKD), but their effect on kidney function remains uncertain. This three-year randomized, placebo-controlled trial tested whether lanreotide could slow kidney function decline in adults with stage 2/3...
This November, the ISN will contribute to nephrology events in Iran, China, Tunisia, and Sri Lanka, sharing expertise through scientific programs and raising awareness of ISN activities and opportunities. 20th International Congress of Nephrology, Dialysis and Transplantation (ICNDT 2026) November 4-6, 2026 Isfahan, Iran A recorded talk by ISN President Marcello Tonelli on the WHO resolution on...
Fiona Loud A delayed kidney disease diagnosis can affect far more than treatment. It can leave people with little time to understand what is happening, prepare for what comes next, or make informed choices about their care. For ISN Patient Liaison Advisory Group member Fiona Loud (UK), the warning signs stretched back years. Kidney damage was...
Keep developing your expertise with knowledge and skills you can apply in clinical practice. Your WCN’27 registration includes complimentary access to a range of in-depth courses* that are designed around focused practical learning, case discussions, and expert exchange. Register for WCN’27 at the early bird rate Explore the full course program Onco-Nephrology Course Do you manage patients whose...
Publishing original research in Kidney International® is already a significant achievement. If you are an eligible early-career researcher, take it further by applying for a KI-ISN Early-Career Researcher Award for the chance to raise the visibility of your work and be recognized at WCN’27. Apply for a KI-ISN Early-Career Researcher Award by December 11, 2026 Why...
More than 70% of greenhouse gas emissions from kidney care come from the supply chain, making procurement systems a key opportunity to reduce environmental impact. A new GREEN-K paper in Kidney International Reports® describes how the ISN-led GREEN-K Working Group developed a proposed global sustainable procurement framework for kidney care. Read the paper The authors combined an...
Vivekanand Jha named editor-in-chief of Kidney International Reports® October 21, 2026 The International Society of Nephrology (ISN) is pleased to announce the appointment of Vivekanand Jha as the next editor-in-chief of Kidney International Reports® (KIR), an official ISN open-access journal. His term will begin on January 1, 2027, succeeding Jai Radhakrishnan, who has been appointed next...
Kidney International® New insights from DAPA-CKD indicate that dapagliflozin modulates key pathways related to kidney outcomes Dapagliflozin improves kidney outcomes in chronic kidney disease (CKD), but the mechanisms behind these benefits are not fully understood. This DAPA-CKD proteomic analysis found that dapagliflozin modifies biological pathways linked to CKD progression, particularly those involving inflammation, fibrosis, and tissue remodeling. The...
This October, the ISN will contribute to nephrology events in France and Bosnia and Herzegovina. 11th Annual Congress of Société Francophone de Néphrologie Dialyse et Transplantation (SFNDT) October 13-16, 2026 Paris, France Join the ISN-ERA Joint Session on Wednesday, October 14, from 14:15-15:30 (Central European Summer Time). ISN Emerging Leaders Program member Yannick Nlandu will moderate the session. 21st...
Wei Chen presenting at the ISN Frontiers meeting in Dalian, China Selected content from the recent ISN Frontiers meeting in Dalian is now available at the ISN Academy. Explore ISN Frontiers content Discover ISN Frontiers industry content Revisit key sessions and industry symposia on emerging treatments, artificial intelligence, rare kidney diseases, cardio-kidney-metabolic care, and more. Explore the Kidney International...
How should clinicians recognize, assess, and manage acute kidney injury (AKI) linked to infections commonly encountered in tropical settings? A new ISN Academy course, “Acute Kidney Injury in the Tropics,” offers a focused review of the pathophysiology, diagnosis, management, and prevention of infection-related AKI, with practical guidance relevant to both adult and pediatric care. Explore the...
Your work has helped move kidney care forward. Could it be time for that contribution to receive international recognition? Professional recognition is more than a title. It can signal to colleagues and patients that an igloball professional community has acknowledged your work, experience, and commitment to kidney care. The Fellow of the International Society of Nephrology...
Want to stay at the forefront of global kidney health, deepen your expertise, collaborate with peers worldwide, and access opportunities that can move your career forward? In 2027, the ISN is making membership even more accessible to kidney health professionals around the world, while continuing to provide the benefits, resources and opportunities members value. Explore the...
Behind every diagnosis is a patient with their own experiences, priorities, and story. Narrative medicine asks clinicians to pay closer attention to these stories and how they can inform medical decision-making. Rita Charon (USA), a professor of medicine, literary scholar, and co-founder of the field of narrative medicine, will present “Narrative Power for Patients and...
